Primary Colour:
Primary Text:
Secondary Colour:
Secondary Text:
Tertiary Colour:
Tertiary Text:
Colour Picker
Preview
FeaturesTypographyTutorials
Module Title
Home
Module Title

This block of text is used as an example for the colour chooser module on this web site. This paragraph is functionally unimportant, and can safely be ignored.

Module Title
Module Title
Instructions

Select a predefined style from the drop-down or choose your own colours via the handy colour-chooser. When you are satisfied with your selection, click the "Apply Colours" button below to store your selection in a cookie.

Apply Colours

Holyrood opinion poll

With the publication of the interim Calman Report, do you think –
 
Home arrow Holyrood news arrow News categories arrow Scottish Parliament (HCL10) arrow Committee to investigate cancer treatment
Committee to investigate cancer treatment Print E-mail
Thursday, 06 March 2008

The Scottish Parliament’s Public Petitions Committee today launched an inquiry into the availability of cancer treatment drugs on the NHS.

The inquiry, which follows a petition from member of the public Tina McGeever about the provision of a cancer treatment drug to her husband Mike Gray, will consider the provision of cancer treatment drugs on the NHS and whether there is equity across NHS boards of the appropriateness, effectiveness and availability of such drugs. It will also consider whether there is parity between the cancer drug treatment regime and other life threatening or terminal conditions, but it will not look into the availability of other drugs on the NHS. 

Committee convener Frank McAveety MSP said: 

"We hope to bring clarity and assistance to those cancer sufferers who may have experienced similar issues to those faced by Mr Gray. We would like to invite written evidence with a view to taking forward oral evidence hearings in April and reporting before the summer recess." 

Further information on the inquiry, including its remit, and how to submit evidence can be viewed on the Committee's web pages

 

No one has commented on this article.
The author or administrator has closed this item for comments.


 

Featured sites

Site news...


Have your say: We have introduced a comments system in our news and magazine article sections, submit your comments for approval. Your comments  will feature in the "Your comments" section.

 
Visitors: 6514035
We have 10 guests online